Max D. Adams

Max D. Adams's AcademicInfluence.com Rankings

Max D. Adams

Literature

#5990

World Rank

#9104

Historical Rank

#2746

USA Rank

Writing

#1757

World Rank

#2277

Historical Rank

#1151

USA Rank

literature Degrees

Download Badge

Literature

Why Is Max D. Adams Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Max D. Adams is an American screenwriter and author. The winner of a Nicholl Fellowship in Screenwriting and an Austin Film Festival screenwriting award, Adams went on to be dubbed “Red Hot Adams” by Daily Variety.

(See a Problem?)

Max D. Adams's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Characterization of viable and nonviable myocardium at MR imaging: comparison of gadolinium-based extracellular and blood pool contrast materials versus manganese-based contrast materials in a rat myocardial infarction model. (2003) (58)
Vasoconstrictor actions of delta8- and delta9-tetrahydrocannabinol in the rat. (1976) (57)
MRI Contrast Enhancement of Necrosis by MP-2269 and Gadophrin-2 in a Rat Model of Liver Infarction (2001) (38)
A cannabinoid with cardiovascular activity but no overt behavioral effects (1977) (33)
Toxicological Assessment of Gadoversetamide Injection (OptiMARK®), a New Contrast-Enhancement Agent for Use in Magnetic Resonance Imaging (2001) (33)
Brain 5-hydroxytryptamine correlates of behavior: Studies involving spontaneously hypertensive (SHR) and normotensive Wistar rats (1976) (30)
Adrenergic receptors in the nucleus tractus solitarii of the rat. (1982) (29)
Neurotoxicity of non-ionic X-ray contrast media after intracisternal administration in rats. (1995) (22)
Histamine and reflex vasodilatation in the rat. (1969) (17)
The Synthesis and Screening of Nonionic Gadolinium (III) DTPA‐Bisamide Complexes as Magnetic Resonance Imaging Contrast Agents (1991) (13)
Characterization of polyethyleneglycol-stabilized, manganese-substituted hydroxylapatite (MnHA-PEG). A potential MR blood pool agent. (1997) (9)
Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat. (1976) (9)
Preliminary evaluation of a polyethyleneglycol‐stabilized manganese‐substituted hydroxylapatite as an intravascular contrast agent for MR angiography (1997) (9)
Altered reflex vasodilatation in the hypertensive rat: possible role of histamine. (1970) (9)
Biodistribution Study of Ethiodized Oil Emulsion 13 for Computed Tomography of the Liver and Spleen (1982) (8)
Characteristics of histamine disposition in vascular smooth muscle. (1976) (8)
Noncardiac applications of Albunex. (1994) (7)
The effect of sodium on the fibrillatory potential of ioversol. (1988) (6)
A rat EEG model for evaluating contrast media neurotoxicity. (1988) (5)
Histamine disposition in the hypertensive rat. (1974) (5)
synthesis and biological testing of nonionic iodinated x-ray contrast media. (1980) (5)
Synthesis and characterization of nonionic paramagnetic metal complexes as potential magnetic resonance imaging contrast agents. (1990) (4)
Development of a novel nonaromatic small-molecule MR contrast agent for the blood pool. (1998) (4)
Ioglucomide: a new nonionic myelographic agent. Preclinical studies. (1981) (4)
Kinetics of a novel blood pool agent (MP-2269) with persistent high relaxivity for MR angiography. (1998) (4)
Manganese hydroxylapatite as a potential magnetic resonance contrast agent for liver imaging. (1994) (3)
1H-NMRD and17O-NMR assessment of water exchange and rotational dynamics of two potential MRI agents: MP-1177 (an extracellular agent) and MP-2269 (a blood pool agent) (1999) (3)
Improving the sonographic contrast produced by Albunex during the inhalation of gases other than air. (1996) (3)
The Effect of Sodium on the Fibrillatory Potential of Ioversol (1988) (2)
Manganese-substututed hydroxyapatites coated with polyethylene glycol diphosphonate: Potential blood-pool agents for magnetic resonance imaging (1996) (1)
RENAL EFFECTS OF IOXAGLIC ACID: PRECLINICAL STUDIES (1984) (1)
PRECLINICAL STUDIES WITH MP 328: A POTENTIAL NONIONIC MYELOGRAPHIC AND ANGIOGRAPHIC CONTRAST AGENT (1984) (1)
FACTORS IN THE DESIGN OF NUCLEAR MAGNETIC RESONANCE IMAGING AGENTS (1984) (1)
A potent antinociceptive cannabinoid which lacks opiate substitution properties in monkeys. (1977) (0)
A Rat EEG Model for Evaluating Contrast Media Neurotoxicity (1988) (0)
IOGLUMIDE: A NEW NONIONIC INTRATHECAL CONTRAST AGENT (1983) (0)
Manganese-substituted hydroxyapatites coated with polyethylene glycol diphosphonate: potential blood-pool agents for magnetic resonance imaging. (1996) (0)
Electroencephalographic effects of intracisternally injected nonionic x-ray contrast media in rats. (1990) (0)

This paper list is powered by the following services:

Other Resources About Max D. Adams

en.wikipedia.org

What Schools Are Affiliated With Max D. Adams?

Max D. Adams is affiliated with the following schools:

University of Utah